Daan W. Hommes

10.6k citations

97 papers · 7.1k indexed · 4 hit papers · h-index 39

Genetics top 0.2%
- Inflammatory Bowel Disease 61
Internal Medicine top 1%
Epidemiology top 0.5%
- Microscopic Colitis 32
- Autoimmune and Inflammatory Disorders 7
Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 7
- Immunotherapy and Immune Responses 5
Gastroenterology top 1%
Oncology
- Pancreatic and Hepatic Oncology Research 5
Hepatology
- Liver Diseases and Immunity 5
Surgery
- Eosinophilic Esophagitis 4

Co-authors: Sander J. H. van Deventer Maikel P. Peppelenbosch Guido N.J. Tytgat Hendrik M. van Dullemen Henri Braat James N. Woody Sander van Deventer Gijs R. van den Brink
Cited by: Genetics Internal Medicine Epidemiology
Journals: The Lancet (1 paper)Journal of Biological Chemistry (1 paper)Circulation (1 paper)
Partner nations: Netherlands United States Germany

In The Last Decade

Daan W. Hommes

93 papers receiving 6.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 Journal of Crohn s and Colitis
2003 Gastroenterology
1995 Gastroenterology
1992 The Lancet

Peers

Countries citing papers authored by Daan W. Hommes

Since Specialization

Citations

This map shows the geographic impact of Daan W. Hommes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daan W. Hommes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daan W. Hommes more than expected).

Fields of papers citing papers by Daan W. Hommes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daan W. Hommes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daan W. Hommes. The network helps show where Daan W. Hommes may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daan W. Hommes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daan W. Hommes Line = papers co-authored together Daan W. Hommes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis Gut ·Paul Rutgeerts,Richard N. Fedorak,Daan W. Hommes,Andreas Sturm,Daniel C. Baumgart,Brian Bressler,Stefan Schreiber,John Mansfield,Marna Williams,Meina Tang,Jennifer Visich,Xiaohui Wei,Mary Keir,Diana Luca,Dimitry M. Danilenko,Jackson G. Egen,Sharon O’Byrne	2012	111
2	A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease PLoS Genetics ·Eleonora A. Festen,Philippe Goyette,Todd J. Green,Gabrielle Boucher,Claudine Beauchamp,Gosia Trynka,P Dubois,Caroline Lagacé,Pieter Stokkers,Daan W. Hommes,Donatella Barisani,Orazio Palmieri,Vito Annese,David A. van Heel,Rinse K. Weersma,Mark J. Daly,Cisca Wijmenga,John D. Rioux	2011	162
3	Inflammatory bowel disease Foreword Expert Review of Clinical Immunology ·Stephen B. Hanauer,Daan W. Hommes	2010	1
4	Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis Gut ·William J. Sandborn,J.‐F. COLOMBEL,Matthew Frankel,Daan W. Hommes,James N. Lowder,L Mayer,Scott E. Plevy,Pieter Stokkers,Simon Travis,Gert Van Assche,Daniel C. Baumgart,Stephan R. Targan	2010	58
5	5-Aminosalicylic acid inhibits TGF-β1 signalling in colorectal cancer cells Cancer Letters ·Pim J. Koelink,Lukas J.A.C. Hawinkels,Eliza Wiercinska,Cornelis F.M. Sier,Peter ten Dijke,C. B. H. W. Lamers,Daan W. Hommes,Hein W. Verspaget	2009	22
6	Circulating cell death products predict clinical outcome of colorectal cancer patients BMC Cancer ·Pim J. Koelink,Cornelis Bhw Lamers,Daan W. Hommes,Hein W. Verspaget	2009	46
7	Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence Gastrointestinal Endoscopy ·David J. van Westerloo,Erik A.J. Rauws,Daan W. Hommes,Alex F. de Vos,Tom van der Poll,Barbara Powers,Paul Fockens,Marcel G. W. Dijkgraaf,Marco J. Bruno	2008	14
8	Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohnʼs disease Inflammatory Bowel Diseases ·M. Meijer,Marij A.C. Mieremet-Ooms,Cornelis F.M. Sier,R. A. van Hogezand,C. B. H. W. Lamers,Daan W. Hommes,Hein W. Verspaget	2008	20
9	MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not British Journal of Cancer ·Alexandra M. J. Langers,Cornelis F.M. Sier,Lukas J.A.C. Hawinkels,F J G M Kubben,W. van Duijn,J.J. van der Reijden,C. B. H. W. Lamers,Daan W. Hommes,Hein W. Verspaget	2008	44
10	A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis Journal of Clinical Gastroenterology ·Daan W. Hommes,Willemien Erkelens,Cyriel Y. Ponsioen,Pieter Stokkers,Erik J. Rauws,Mirjam van der Spek,Fiebo ten Kate,S J van Deventer	2008	87
11	Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients British Journal of Cancer ·Lukas J.A.C. Hawinkels,Hein W. Verspaget,W. van Duijn,J. M. Van Der Zon,Kim Zuidwijk,F J G M Kubben,Jan H. Verheijen,Daan W. Hommes,C. B. H. W. Lamers,Cornelis F.M. Sier	2007	72
12	Abstract 1497: Enhanced atherogenesis and altered High Density Lipoprotein in patients with Crohn's Disease Circulation ·Sander I. van Leuven,Rachel Hezemans,Han Levels,S J van Deventer,John J.P. Kastelein,Erik S.G. Stroes,Eric de Groot,Daan W. Hommes	2006	1
13	A combined regimen of infliximab and azathioprine induces better endoscopic healing than classic step-up therapy in newly diagnosed Crohn's disease Gastroenterology ·G. D’Haens,Daan W. Hommes,F Baert,Martine De Vos,F Caenepeel,Gert Van Assche,Guy Lambrecht,J.-C. Coche,Séverine Vermeire,Morgan Camp	2006	20
14	Immunology of Crohn's Disease Annals of the New York Academy of Sciences ·Henri Braat,Maikel P. Peppelenbosch,Daan W. Hommes	2006	27
15	Short-Term Outcomes after Laparoscopic Ileocolic Resection for Crohn’s Disease Digestive Surgery ·Sebastiaan W. Polle,Jan Wind,Dirk T. Ubbink,Daan W. Hommes,Dirk J. Gouma,Willem A. Bemelman	2006	51
16	Once daily MMX mesalazine for the treatment of mild‐to‐moderate ulcerative colitis: a phase II, dose‐ranging study Alimentary Pharmacology & Therapeutics ·Geert D’Haens,Daan W. Hommes,L.G.J.B. Engels,F Baert,Laurens van der Waaij,Patrick Connor,John Ramage,Olivier Dewit,Mary Palmen,David D. Stephenson,Richard J. Joseph	2006	66
17	Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function American Journal of Clinical Nutrition ·Henri Braat,Jan Van den Brande,Erik van Tol,Daan W. Hommes,Maikel P. Peppelenbosch,Sander van Deventer	2004	180
18	Increased expression of DC‐SIGN⁺IL‐12⁺IL‐18⁺ and CD83⁺IL‐12^–IL‐18^– dendritic cell populations in the colonic mucosa of patients with Crohn's disease European Journal of Immunology ·Anje A. te Velde,Yvette van Kooyk,Henri Braat,Daan W. Hommes,Trees A. M. Dellemijn,J. Frederik M. Slors,Sander J. H. van Deventer,Florry A. Vyth‐Dreese	2002	117
19	Beneficial Effect of Treatment with a Monoclonal Anti-Tumor Necrosis Factor-α Antibody on Markers of Coagulation and Fibrinolysis in Patients with Active Crohn’s Disease Pathophysiology of Haemostasis and Thrombosis ·Daan W. Hommes,Hendrik M. van Dullemen,Micha Levi,Arie van der Ende,J. Woody,G. N. J. Tytgat,Sander J. H. van Deventer	1997	38
20	Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis European Journal of Gastroenterology & Hepatology ·John Meenan,Tim A. Grool,Daan W. Hommes,Sophie Dijkhuizen,Fibo J. ten Kate,Michael L. Wood,Michael R. Whittaker,Guido N.J. Tytgat,S J van Deventer	1996	24

About Daan W. Hommes

Daan W. Hommes is a scholar working on Genetics, Gastroenterology and Epidemiology, having authored 97 papers that have together received 7.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (61 papers), Microscopic Colitis (32 papers), Autoimmune and Inflammatory Disorders (7 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Immunotherapy and Immune Responses (5 papers), Liver Diseases and Immunity (5 papers) and Eosinophilic Esophagitis (4 papers). The work is most often cited by research in Genetics (3.8k citations), Internal Medicine (435 citations) and Epidemiology (2.5k citations). Daan W. Hommes has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Sander J. H. van Deventer, Maikel P. Peppelenbosch, Guido N.J. Tytgat, Hendrik M. van Dullemen, Henri Braat, James N. Woody, Sander van Deventer, Gijs R. van den Brink, Gert Van Assche and Axel Dignaß. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact